SCD Stem Cell Mobilization and Apheresis Using Motixafortide
SCD Stem Cell Mobilization and Apheresis Using Motixafortide
Recruiting · NCT06442761 · Registry updated 2026-09-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SCD Stem Cell Mobilization and Apheresis Using Motixafortide | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Recruiting | Phase 1 | 2026-09-08 | NCT06442761 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ayrmid Ltd | 1 |
| St. Jude Children's Research Hospital | 169 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Heart, Blood and Lung Institute-Cellular and Molecular Therapy Branch | Bethesda | United States | 1 |
| St. Jude Children's Research Hospital | Memphis | United States | 194 |
| University of Alabama at Birmingham | Birmingham | United States | 247 |